Priming with DNA vaccine and boosting with killed vaccine conferring protection of chickens against infectious bursal disease

Vaccine

Volumn 25, Issue 29, 2007, Pages 5417-5427

  Hsieh, Ming Kun ^a   Wu, Ching Ching ^a   Lin, Tsang Long ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

DNA vaccine; IBDV; Infectious bursal disease; Prime and boost

Indexed keywords

DNA VACCINE; PLASMID DNA; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CHICKEN; CONTROLLED STUDY; DRUG DOSE COMPARISON; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; INFECTIOUS BURSAL DISEASE VIRUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RNA VIRUS INFECTION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; ATROPHY; BIRNAVIRIDAE INFECTIONS; BODY WEIGHT; BURSA OF FABRICIUS; CELL PROLIFERATION; CHICKENS; IMMUNIZATION, SECONDARY; INFECTIOUS BURSAL DISEASE VIRUS; INJECTIONS, INTRAMUSCULAR; LYMPHOCYTES; NEUTRALIZATION TESTS; ORGAN SIZE; PLASMIDS; POULTRY DISEASES; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINATION; VACCINES, DNA; VIRAL VACCINES;

EID: 34250880127     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.04.087     Document Type: Article

References (36)

1. Dobos P., Hill B.J., Hallett R., Kells D.T., Becht H., and Teninges D. Biophysical and biochemical characterization of five animal viruses with bisegmented double-stranded RNA genomes. J Virol 32 2 (1979) 593-605
2. Muller H., and Nitschke R. The two segments of the infectious bursal disease virus genome are circularized by a 90,000-Da protein. Virology 159 1 (1987) 174-177
3. Rosenberger J.K., and Cloud S.S. The effects of age, route of exposure, and coinfection with infectious bursal disease virus on the pathogenicity and transmissibility of chicken anemia agent (CAA). Avian Dis 33 4 (1989) 753-759
4. Mundt E., Beyer J., and Muller H. Identification of a novel viral protein in infectious bursal disease virus-infected cells. J Gen Virol 76 Pt 2 (1995) 437-443
5. Azad A.A., Jagadish M.N., Brown M.A., and Hudson P.J. Deletion mapping and expression in Escherichia coli of the large genomic segment of a birnavirus. Virology 161 1 (1987) 145-152
6. Spies U., Muller H., and Becht H. Properties of RNA polymerase activity associated with infectious bursal disease virus and characterization of its reaction products. Virus Res 8 2 (1987) 127-140
7. Becht H., Muller H., and Muller H.K. Comparative studies on structural and antigenic properties of two serotypes of infectious bursal disease virus. J Gen Virol 69 (1988) 631-640
8. Fahey K.J., O'Donnell I.J., and Azad A.A. Characterization by Western blotting of the immunogens of infectious bursal disease virus. J Gen Virol 66 Pt 7 (1985) 1479-1488
9. Mardassi H., Khabouchi N., Ghram A., Namouchi A., and Karboul A. A very virulent genotype of infectious bursal disease virus predominantly associated with recurrent infectious bursal disease outbreaks in Tunisian vaccinated flocks. Avian Dis 48 4 (2004) 829-840
10. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., et al. Direct gene transfer into mouse muscle in vivo. Science 247 4949 Pt 1 (1990) 1465-1468
11. Woodland D.L. Jump-starting the immune system: prime-boosting comes of age. Trends Immunol 25 2 (2004) 98-104
12. McShane H. Prime-boost immunization strategies for infectious diseases. Curr Opin Mol Ther 4 1 (2002) 23-27
13. Newman M.J. Heterologous prime-boost vaccination strategies for HIV-1: augmenting cellular immune responses. Curr Opin Invest Drugs 3 3 (2002) 374-378
14. Ramshaw I.A., and Ramsay A.J. The prime-boost strategy: exciting prospects for improved vaccination. Immunol Today 21 4 (2000) 163-165
15. Morello C.S., Ye M., and Spector D.H. Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication. J Virol 76 10 (2002) 4822-4835
16. Larsen D.L., Karasin A., and Olsen C.W. Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting. Vaccine 19 20-22 (2001) 2842-2853
17. Hsieh M.K., Wu C.C., and Lin T.L. The effect of co-administration of DNA carrying chicken interferon-gamma gene on protection of chickens against infectious bursal disease by DNA-mediated vaccination. Vaccine 24 47/48 (2006) 6955-6965
18. Rodriguez-Chavez I.R., Rosenberger J.K., and Cloud S.S. Characterization of the antigenic, immunogenic, and pathogenic variation of infectious bursal disease virus due to propagation in different host systems (bursa, embryo, and cell culture). I. Antigenicity and immunogenicity. Avian Pathol 31 5 (2002) 463-471
19. Loa C.C., Lin T.L., Wu C.C., Bryan T., Thacker H.L., Hooper T., et al. Humoral and cellular immune responses in turkey poults infected with turkey coronavirus. Poult Sci 80 10 (2001) 1416-1424
20. Wolff J.A., Ludtke J.J., Acsadi G., Williams P., and Jani A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1 6 (1992) 363-369
21. Busch D.H., and Pamer E.G. T cell affinity maturation by selective expansion during infection. J Exp Med 189 4 (1999) 701-710
22. Rees W., Bender J., Teague T.K., Kedl R.M., Crawford F., Marrack P., et al. An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. Proc Natl Acad Sci USA 96 17 (1999) 9781-9786
23. Whalen B.J., Tony H.P., and Parker D.C. Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by Ia-restricted Th2 helper T cell lines. J Immunol 141 7 (1988) 2230-2239
24. Klinman D.M., Yi A.K., Beaucage S.L., Conover J., and Krieg A.M. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci USA 93 7 (1996) 2879-2883
25. Klinman D.M., Yamshchikov G., and Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol 158 8 (1997) 3635-3639
26. Hoshi S., Nakamura T., Nunoya T., and Ueda S. Induction of protective immunity in chickens orally immunized with inactivated infectious bursal disease virus. Vaccine 13 3 (1995) 245-252
27. Giambrone J.J., and Clay R.P. Vaccination of day-old broiler chicks against Newcastle disease and infectious bursal disease using commercial live and/or inactivated vaccines. Avian Dis 30 3 (1986) 557-561
28. Chang H.C., Lin T.L., and Wu C.C. DNA-mediated vaccination against infectious bursal disease in chickens. Vaccine 20 3/4 (2001) 328-335
29. Kim I.J., Karaca K., Pertile T.L., Erickson S.A., and Sharma J.M. Enhanced expression of cytokine genes in spleen macrophages during acute infection with infectious bursal disease virus in chickens. Vet Immunol Immunopathol 61 2-4 (1998) 331-341
30. Kim I.J., Gagic M., and Sharma J.M. Recovery of antibody-producing ability and lymphocyte repopulation of bursal follicles in chickens exposed to infectious bursal disease virus. Avian Dis 43 3 (1999) 401-413
31. Sharma J.M., and Fredericksen T.L. Mechanism of T cell immunosuppression by infectious bursal disease virus of chickens. Prog Clin Biol Res 238 (1987) 283-294
32. Sharma J.M., and Lee L.F. Effect of infectious bursal disease on natural killer cell activity and mitogenic response of chicken lymphoid cells: role of adherent cells in cellular immune suppression. Infect Immun 42 2 (1983) 747-754
33. Kim S.J., Sung H.W., Han J.H., Jackwood D., and Kwon H.M. Protection against very virulent infectious bursal disease virus in chickens immunized with DNA vaccines. Vet Microbiol 101 1 (2004) 39-51
34. Mahmood M.S., Siddique M., Hussain I., Khan A., and Mansoor M.K. Protection capability of recombinant plasmid DNA vaccine containing VP2 gene of very virulent infectious bursal disease virus in chickens adjuvanted with CpG oligodeoxynucleotide. Vaccine 24 22 (2006) 4838-4846
35. Siegrist C.A., Barrios C., Martinez X., Brandt C., Berney M., Cordova M., et al. Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice. Eur J Immunol 28 12 (1998) 4138-4148
36. Endsley J.J., Roth J.A., Ridpath J., and Neill J. Maternal antibody blocks humoral but not T cell responses to BVDV. Biologicals 31 2 (2003) 123-125